News

Media

Conferences

Publications

Clinical

Events

Resources

How Provider Status Would Change Independent Pharmacy Practice

February 19, 2015

Video

Dan Benamoz, RPh, president and CEO of Pharmacy Development Services, talks about how provider status could change independent pharmacy practice.

Dan Benamoz, RPh, president and CEO of Pharmacy Development Services, talks about how provider status could change independent pharmacy practice.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.

Recent Videos

Image credit: Gorodenkoff | stock.adobe.com

Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com

Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com

Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com

Image Credit: © Anastasiia - stock.adobe.com

Related Content

Pregnant woman -- Image credit: Syda Productions | stock.adobe.com

Analysis Findings Indicate Relationship Between Maternal Asthma and Risk for Autism Spectrum Disorders

Gillian McGovern, Assistant Editor

Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

Image Credit: © Africa Studio - stock.adobe.com

FDA Approves IncobotulinumtoxinA for the Simultaneous Treatment of Upper Facial Lines

Alexandra Gerlach, Associate Editor

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Man and woman hiking in Infected ticks forest with warning sign. Risk of tick-borne and lyme disease - Image credit: 24K-Production | stock.adobe.com

During Summer Months, Counsel Patients on Preventing Lyme Disease

Sofiya Volynsky, PharmD;Atosa Nazemi, PharmD;Melissa Russo, PharmD;Bruce Roberts, PharmD;Mandy Hoysan, PharmD

Medicine law concept. Judges gavel with pills - Image credit: Iren Moroz | stock.adobe.com

The Ethics and Economics of California’s End of Life Option Act

Sawyer Y. Mustopoh;Joseph L. Fink III, JD, BSPharm, DSc (Hon), FAPhA

Related Content

Pregnant woman -- Image credit: Syda Productions | stock.adobe.com

Analysis Findings Indicate Relationship Between Maternal Asthma and Risk for Autism Spectrum Disorders

Gillian McGovern, Assistant Editor

Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

Image Credit: © Africa Studio - stock.adobe.com

FDA Approves IncobotulinumtoxinA for the Simultaneous Treatment of Upper Facial Lines

Alexandra Gerlach, Associate Editor

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Man and woman hiking in Infected ticks forest with warning sign. Risk of tick-borne and lyme disease - Image credit: 24K-Production | stock.adobe.com

During Summer Months, Counsel Patients on Preventing Lyme Disease

Sofiya Volynsky, PharmD;Atosa Nazemi, PharmD;Melissa Russo, PharmD;Bruce Roberts, PharmD;Mandy Hoysan, PharmD

Medicine law concept. Judges gavel with pills - Image credit: Iren Moroz | stock.adobe.com

The Ethics and Economics of California’s End of Life Option Act

Sawyer Y. Mustopoh;Joseph L. Fink III, JD, BSPharm, DSc (Hon), FAPhA

Consent Preferences

Clinical Forums

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.